Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Journal of Medicinal Chemistry|December 19, 2013
Novel S1P(1) receptor agonists--part 2: from bicyclo[3.1.0]hexane-fused thiophenes to isobutyl substituted thiophenesMartin H Bolli, Jörg Velker, Claus Müller, et al.Hypertension (Dallas, Tex. : 1979)|March 2, 2011
Identification of cathepsin L as a potential sex-specific biomarker for renal damageYasmina Bauer, Patrick Hess, Changbin Qiu, et al.Bioorganic & Medicinal Chemistry Letters|October 27, 2009
New classes of potent and bioavailable human renin inhibitorsL'ubos Remen, Olivier Bezençon, Sylvia Richard-Bildstein, et al.American Journal of Respiratory Cell and Molecular Biology|July 17, 2014
A novel genomic signature with translational significance for human idiopathic pulmonary fibrosisYasmina Bauer, John Tedrow, Simon de Bernard, et al.Journal of Medicinal Chemistry|April 11, 2009
Design and preparation of potent, nonpeptidic, bioavailable renin inhibitorsOlivier Bezençon, Daniel Bur, Thomas Weller, et al.Journal of Medicinal Chemistry|April 14, 2017
Synthesis and Characterization of Tetrahydropyran-Based Bacterial Topoisomerase Inhibitors with Antibacterial Activity against Gram-Negative BacteriaJean-Philippe Surivet, Cornelia Zumbrunn, Thierry Bruyère, et al.Journal of Medicinal Chemistry|November 26, 2013
Novel S1P1 receptor agonists--part 1: From pyrazoles to thiophenesMartin H Bolli, Claus Müller, Boris Mathys, et al.Nature Medicine|January 30, 2007
Promotion of sleep by targeting the orexin system in rats, dogs and humansCatherine Brisbare-Roch, Jasper Dingemanse, Ralf Koberstein, et al.Journal of Medicinal Chemistry|May 8, 2010
2-imino-thiazolidin-4-one derivatives as potent, orally active S1P1 receptor agonistsMartin H Bolli, Stefan Abele, Christoph Binkert, et al.Journal of Medicinal Chemistry|December 26, 2013
Novel S1P(1) receptor agonists--part 3: from thiophenes to pyridinesMartin H Bolli, Stefan Abele, Magdalena Birker, et al.Pageof 5